is tirzepatide compound ending The FDA has proposed to bar 503B outsourcing facilities from bulk compounding semaglutide and tirzepatide. The shortage-list pathway already closed in 2024 and 2025; this proposal would remove the remaining bulks-list route Tirzepatide, FDA, and Compounding: Understanding

The SURMOUNT-4 discontinuation data The SURMOUNT-4 trial specifically studied what happens when you stop tirzepatide after successful weight loss

Telehealth programs focused on weight or metabolic health

The 72-hour rule and changing your injection day Life does not always cooperate with weekly schedules

While the base-case analysis showed numerical differences in cost of control between tirzepatide and semaglutide, the 95% confidence intervals around the mean estimates overlapped at all thresholds

This is exactly where a physician matters

Book an appointment with one of our board-certified primary care doctors to discuss options for your weight loss journey, including brand name GLP-1 and compounded semaglutide if you cannot access brand name medications